Home 
Bratislava Medical Journal 2021 Bratislava Medical Journal Vol.122, No.10, p.744–747,2021
Bratislava Medical Journal 2021 Bratislava Medical Journal Vol.122, No.10, p.744–747,2021
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.122, No.10, p.744–747,2021 |
||
| Title: The prognostic significance of vitamin D deficiency in patients with COVID-19 pneumonia | ||
| Author: M. Yildiz, M. U. Senel, S. Kavurgaci, F. E. Ozturk, A. Ozturk | ||
| Abstract: BACKGROUND: Vitamin D has anti-inflammatory and immunomodulatory effects via the downregulation of pro-inflammatory cytokines. We aimed to demonstrate the effect of vitamin D levels on survival in COVID-19 patients. MATERIALS AND METHODS: 207 COVID-19 patients were included in the study. Serum vitamin D levels were measured, and patients with levels <20 ng/ml or 21 to 30 ng received a single 300.000 IU dose of vitamin D. RESULTS: Of 207 patients, 37 received vitamin D, while 170 did not. Demographic, radiologic and mean laboratory values were similar between the groups. The mean plasma vitamin D level without vitamin D support (n=170) was 50.82±16.12 ng/ml (30.28–81.35) vs. 16.98±6.2 ng/ml (4.20–28.30) in vitamin D group. The most remarkable finding were the mortality rates; while only 1 patient (2.7 %) died in the vitamin D group, 24 patients (14.1 %) died in no vitamin D supplementation group (p=0.038). CONCLUSION: Although a few retrospective studies put forth a relation between vitamin D deficiency and COVID-19 course severity there is still paucity of data about the efficacy of vitamin supplementations in COVID-19 patients. A single 300.000 IU dose of vitamin D seems to represent a useful, practical, and safe adjunctive approach for the treatment or prevention of COVID-19 (Tab. 1, Fig. 1, Ref. 30). |
||
| Keywords: vitamin D, COVID-19, prognosis. | ||
| Published online: 27-Sep-2021 | ||
| Year: 2021, Volume: 122, Issue: 10 | Page From: 744, Page To: 747 | |
| doi:10.4149/BLL_2021_119 |
||
|
|
 download file |
|